Donley Matthew Maxwell

Average Profitability
67.17%
Insider Buys Quantity
2
Insider Buys Sum
$246,077.08
Insider Sells Quantity
2
Insider Sells Sum
$260,718.67

Insider Activity of Donley Matthew Maxwell

According to the SEC Form 4 filings, Donley Matthew Maxwell, being in a position of

  1. EVP, Ops & Strategy at Aurinia Pharmaceuticals Inc.,
    оver the last 12 months, has bought 0 shares, and sold 40665 shares for $224,064,
    over all time since 2021-05-11, has bought 29800 shares for $246,077, and sold 43717 shares for $260,719.

The largest purchase of all time was on 2021-05-11 and amounted to 19800 shares of Aurinia Pharmaceuticals Inc. for $199,477.

The largest sale of all time was on 2024-03-06 and amounted to 40665 shares of Aurinia Pharmaceuticals Inc. for $224,064.

Biography of Donley Matthew Maxwell

No biography is available at this moment.

2024-03-06SaleAurinia Pharmaceuticals Inc.
AUPH
EVP, Ops & Strategy
40,665
0.0282%
$5.51$224,064-1.27%
2022-11-21PurchaseAurinia Pharmaceuticals Inc.
AUPH
Ex VP, Internal Operations
10,000
0.0071%
$4.66$46,600+96.77%
2022-03-02SaleAurinia Pharmaceuticals Inc.
AUPH
Ex VP, Intern'l Operations
3,052
0.0022%
$12.01$36,655-27.71%
2021-05-11PurchaseAurinia Pharmaceuticals Inc.
AUPH
Ex VP, Intern'l Operations
19,800
0.0139%
$10.07$199,477+37.58%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.